Women with PCOS more likely to be diagnosed with additional medical conditions, study shows

Polycystic ovary syndrome (PCOS) is the most common endocrine disorder in women of reproductive age. In a study published in Acta Obstetricia et Gynecologica Scandinavica, women with PCOS were more likely than other women to also be diagnosed with migraine, hypertension, tendinitis, osteoarthritis, and endometriosis.  Affected women were also using medications more often and reported their own health to be poorer than women without PCOS. 

The study included 246 women with PCOS symptoms or diagnoses and 1,573 controls who were surveyed during their late reproductive years at age 46. 

PCOS is often labeled as a reproductive concern; however, in most cases this is well managed with fertility treatments. Our study underscores the need for health professionals to acknowledge the risk for several comorbidities and increased health burden related to this common syndrome. Women should also be aware of this risk, and they should be supported by early diagnosis and treatment."

Terhi T. Piltonen, MD, PhD, senior author, professor, University of Oulu, Finland

Source:
Journal reference:

Kujanpää, L., et al. (2022) Women with polycystic ovary syndrome are burdened with multimorbidity and medication use independent of body mass index at late fertile age: A population-based cohort study. Acta Obstetricia et Gynecologica Scandinavica. doi.org/10.1111/aogs.14382.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Pfizer-BioNTech vaccine provides strong protection against MIS-C in children aged 5–17